Erchonia Corporation today announces a joint development agreement with InnerScope Hearing Technologies to conduct clinical research and trials for the purpose of obtaining 510(k) clearances from the FDA for 3LT devices to treat hearing-related conditions, including tinnitus.
“We’re hopeful our partnership with InnerScope can make a real difference in patients’ lives and eventually provide a scientifically-proven, non-invasive option.”
この情報へのアクセスはメンバーに限定されています。ログインしてください。メンバー登録は下記リンクをクリックしてください。